Advent International and Warburg Pincus Acquire Baxter's BioPharma Solutions to Form Simtra BioPharma Solutions

STADA Acquires Biopharma's Pharmaceutical Prescription and Consumer Health Business

December 12, 2019

Pharmaceuticals

The STADA Group agreed to acquire the pharmaceutical prescription and consumer health business of Ukrainian producer Biopharma, including GMP-certified production facilities in Bila Tserkva. The deal integrates Biopharma's pharma operations into STADA's European organization, expands STADA's local production footprint in Ukraine and is subject to Ukrainian merger control; Biopharma's shareholders will retain the company's plasma business.

Cambrex Acquires Avista Pharma Solutions

January 2, 2019

Pharmaceuticals

Cambrex Corporation completed the acquisition of Avista Pharma Solutions from Ampersand Capital Partners in a transaction announced November 20, 2018 and completed January 2019 (reported consideration about $252 million). The deal brings Avista’s early‑stage drug development, analytical/testing and finished dosage capabilities (sites in Longmont, CO; Durham, NC; Agawam, MA; and Edinburgh, UK) into Cambrex’s global CDMO network to expand capabilities and cross‑sell services.

Northwest Biotherapeutics Acquires Advent BioServices Ltd.

October 26, 2025

Biotechnology

Northwest Biotherapeutics (NWBio) has completed the acquisition of Advent BioServices Ltd., making Advent a wholly owned subsidiary. The deal transfers Advent's fixed assets, intellectual property and cryostorage capabilities to NWBio to support scale-up and integration of manufacturing capacity for NWBio's DCVax immunotherapy programs.

TricorBraun Acquires Packaging Solutions, Inc.

January 7, 2020

Packaging

TricorBraun has acquired Minneapolis-based Packaging Solutions, Inc. (PSI), a rigid packaging distributor and custom designer serving pharmaceutical, pet food and personal care markets. The acquisition strengthens TricorBraun’s Minneapolis presence (adding warehouse capacity) and integrates PSI into the TricorBraun platform; PSI’s owners and team will remain and the Packaging Solutions name has been retired. Terms were not disclosed.

Bora Pharmaceuticals Acquires Upsher-Smith Laboratories

August 5, 2025

Pharmaceuticals

Bora Pharmaceuticals completed a 2024 acquisition of Upsher-Smith Laboratories for $210 million and is expanding the Maple Grove, Minnesota manufacturing site with a multi-year buildout. The investment includes installation of a Gerteis Macro-Pactor (operational Q3 2025) and development of 100,000 square feet of shell space to boost oral solid dose (OSD) contract development and manufacturing capabilities.

Adare Pharma Solutions Acquires Frontida BioPharm

December 1, 2021

Pharmaceuticals

Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.